New approaches to the minimally invasive treatment of adrenal lesions

Cancer Journal

Volumn 11, Issue 1, 2005, Pages 64-72

  Ogilvie, Jennifer Braemar ^a   Duh, Quan Yang ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal; Complications; Hand assisted adrenalectomy; Indications; Laparoscopic adrenalectomy; Technique

Indexed keywords

DEXAMETHASONE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CYST; ADRENAL METASTASIS; ADRENAL TUMOR; ADRENALECTOMY; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; FOLLOW UP; GANGLIONEUROMA; HOSPITALIZATION; HUMAN; LAPAROSCOPY; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH; ADRENAL DISEASE; METHODOLOGY;

ADRENAL GLAND DISEASES; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; HUMANS; LAPAROSCOPY; PHEOCHROMOCYTOMA;

EID: 20144383546     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200501000-00010     Document Type: Review

References (77)

1. Laser highlights. Newsl Clin Appl 1991;2:1.
2. Gagner M, Lacroix A, Bolte E. Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma [letter]. N Engl J Med 1992;327:1033.
3. Gagner M, Lacroix A, Prinz RA et al. Early experience with laparoscopic approach for adrenalectomy. Surgery 1993;114:1120-1125.
4. Mercan S, Seven R, Ozarmagan S et al. Endoscopic retroperitoneal adrenalectomy. Surgery 1995;118:1071-1076.
5. Prinz RA. A comparison of laparoscopic and open adrenalectomies. Arch Surg 1995;130:489-494.
6. Thompson GB, Grant CS, van Heerden JA et al. Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 1997;122:1132-1136.
7. Brunt LM, Doherty GM, Norton JA et al. Laparoscopic adrenalectomy compared to open adrenalectomy for benign adrenal neoplasms. J Am Coll Surg 1996;183:1-10.
8. Duh QY. American Association of Endocrine Surgeons Presidential Address: Minimally invasive endocrine surgery - standard of treatment or hype? Surgery 2003;134:849-857.
9. Jossart GH, Burpee SE, Gagner M. Surgery of the adrenal glands. Endocrinol Metab Clin North Am 2000;29:57-68.
10. Heniford BT, Arca MJ, Walsh RM et al. Laparoscopic adrenalectomy for cancer. Semin Surg Oncol 1999;16:293-306.
11. Henry JF, Sebag F, Iacobone M et al. Results of laparoscopic adrenalectomy for large and potentially malignant tumors. World J Surg 2002;26:1043-1047.
12. MacGillivray DC, Whalen GF, Malchoff CD et al. Laparoscopic resection of large adrenal tumors. Ann Surg Oncol 2002;9:480-485.
13. Lal G, Duh QY. Laparoscopic adrenalectomy: indications and technique. Surg Oncol 2003;12:105-123.
14. Kebebew E, Siperstein AE, Clark OH et al. Results of laparoscopic adrenalectomy for suspected and unsuspected malignant adrenal neoplasms. Arch Surg 2002;137:948-953.
15. National Institutes of Health State-of-the-Science Conference Statement: Management of the clinically inapparent adrenal mass (incidentaloma), final statement July 16, 2002. http://consensus.nih.gov/ta/021/021_statement.htm.
16. Kloos RT, Gross MD, Francis IR et al. Incidentally discovered adrenal masses. Endocr Rev 1995;16:460-484.
17. Young WF Jr. Management approaches to adrenal incidentalomas. Endocrinol Metab Clin North Am 2000;29:159-185.
18. Kebebew E, Siperstein AE, Duh Q-Y. Laparoscopic adrenalectomy: the optimal surgical approach. J Laparoendosc Adv Surg Tech 2001;11:409-413.
19. Schwartz GL, Turner ST. Prevalence of unrecognized primary aldosteronism in essential hypertension. Am J Hypertens 2002;15:18A.
20. Thompson GB, Young WF Jr. Adrenal incidentaloma. Curr Opin Oncol 2003;15:84-90.
21. Latronico AC, Chrousos GP. Extensive personal experience: adrenocortical tumors. J Clin Endocrinol Metab 1997;82:1317.
22. Conn JW. Presidential address. Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 1955;45:6-17.
23. Beckers A, Abs R, Willems PJ et al. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type I (MEN-I): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN-I locus. J Clin Endocrinol Metab 1992;75:564.
24. Stewart PM. Mineralocorticoid hypertension. Lancet 1999;353:1341-1347.
25. Blumenfeld JD. Hypertension and adrenal disorders. Curr Opin Nephrol Hypertens 1993;2(2):274-282.
26. Young WF Jr. Primary aldosteronism: management issues. Ann NY Acad Sci 2002;970:61-76.
27. Calhoun DA, Nishizaka MK, Zaman MA et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002;40:892-896.
28. Gordon RD, Stowasser M, Tunny TJ et al. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994;21:315-318.
29. Rossi E, Regolisti G, Negro A et al. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 2002;15:896-902.
30. Loh KC, Koay ES, Khaw MC et al. Prevalence of primary aldosteronism among Asian hypertensives in Singapore. J Clin Endocrinol Metab 2000;85:2854-2859.
31. Fardella C, Mosso L, Gomez-Sanchez C et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000;85:1863-1867.
32. Young WF Jr. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinol 2003;144:2208-2213.
33. Al Fehaily M, Duh QY. Clinical manifestation of aldosteronoma. Surg Clin North Am 2004;84:887-905.
34. Rossi GP, Sacchetto A, Chiesura-Corona M et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001;86:1083-1090.
35. Young WF Jr, Stanson AW, Thompson GB et al. Role for adrenal venous sampling in primary aldosteronism. Surgery 2004;136(6):1227-1235.
36. Sawka AM, Young WF Jr, Thompson GB et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001;135:258-261.
37. Celen O, O'Brien MJ, Melby JC et al. Factors influencing outcome of surgery for primary aldosteronism. Arch Surg 1996;131:646-650.
38. Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann NY Acad Sci 2002;970:89-100.
39. Rossi GP, Sacchetto A, Visentin P et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996;27:1039-1045.
40. Abe M, Hamada M, Matsuoka H et al. Myocardial scintigraphic characteristics in patients with primary aldosteronism. Hypertension 1994;23:1164-1167.
41. Midorikawa S, Sanada H, Hashimoto S et al. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol 2001;54:797-804.
42. Barzon L, Fallo F, Soninon N et al. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002;146:61-66.
43. Osella G, Terzolo M, Reimondo G et al. Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 1997;82:3303-3307.
44. Hawn MT, Cook D, Deveney C et al. Quality of life after bilateral adrenalectomy for Cushing's disease. Surgery 2002;132:1064-1068.
45. Welbourn RB. The adrenal glands. In: Welbourn WB, ed. The History of Endocrine Surgery. New York: Praeger, 1990:184.
46. Kvale WF, Roth GM, Manger WM et al. Pheochromocytoma. Circulation 1956;14:622-630.
47. Brunjes S, Johns VJ, Crane MG. Pheochromocytoma: postoperative shock. N Engl J Med 1960;262:393-396.
48. Plouin PF, Duclos JM, Soppelsa F et al. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 2001;86:1480-1486.
49. Duh QY. Evolving surgical management for patients with pheochromocytoma [editorial]. J Clin Endocrinol Metab 2001;86:1477-1479.
50. Cheah WK, Clark OH, Horn JK et al. Laparoscopic adrenalectomy for pheochromocytoma. World J Surg 2002;26:1048-1051.
51. Outwater EK, Siegelman ES, Radecki PD et al. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical shift MR imaging. Am J Roentgenol 1995;165:579-583.
52. Mitchell DG, Crovello M, Matteuci T et al. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992;185:345-351.
53. Barzon L, Scaroni C, Sonino N et al. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999;84:520-526.
54. Porcaro AB, Novella G, Ficarra V et al. Incidentally discovered adrenal myelolipoma: report on 3 operated patients and update of the literature. Arch Ital Urol Androl 2002;74:146-151.
55. Thompson GB, Young WF Jr. Adrenal incidentaloma. Curr Opin Oncol 2003;15:84-90.
56. Vassilopoulou-Sellin R, Schultz PN. Adrenocortical carcinoma: clinical outcome at the end of the 20th century. Cancer 2001;92:1113-1121.
57. Icard P, Chapius Y, Andreassian B et al. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992;112:972.
58. Wooten MD, King DK. Adrenal cortical carcinoma: epidemiology and treatment with mitotane and a review of the literature. Cancer 1993;72:3145-3155.
59. Fishman EK, Deutch BM, Hartman DS et al. Primary adrenocortical carcinoma: CT evaluation with clinical correlation. AJR Am J Roentgenol 1987;148:531-535.
60. Sturgeon C, Kebebew E. Laparoscopic adrenalectomy for malignancy. Surg Clin North Am 2004;84:755-774.
61. van Heerden JA, Roland JF, Carney JA et al. Long-term evaluation following resection of apparently benign pheochromocytoma(s)/paraganglioma(s). World J Surg 1990;14:325-329.
62. Linnoila RI, Keiser HR, Steinberg SM et al. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Hum Pathol 1990:21:1168-1180.
63. Salmenkivi K, Haglund C, Ristimaki A et al. Increased expression of cyclooxygenase-2 in malignant pheochromocytoma. J Clin Endocrinol Metab 2001;86:5615-5619.
64. 131I- metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 2003;98:239-248.
65. Yun M, Kim W, Alnafisi N et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001;42:1795-1799.
66. Wade TP, Longo WE, Virgo KS et al. A comparison of adrenalectomy with other resections for metastatic cancers. Am J Surg 1998;175:183-186.
67. Paul CA, Virgo KS, Wade TP et al. Adrenalectomy for isolated adrenal metastases from non-adrenal cancer. Int J Oncol 2000;17:181-187.
68. Sarela AI, Murphy I, Coit DG et al. Metastasis to the adrenal gland: the emerging role of laparoscopic surgery. Ann Surg Oncol 2003;10:1191-1196
69. Hege KM, Carbone DP. Lung cancer vaccines and gene therapy. Lung Cancer 2003;41:S103-113.
70. Berzofsky JA, Terabe M, Oh S et al. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J Clin Invest 2004;113:1515-1525.
71. Lee JE, Curley SA, Gagel RF et al. Cortical-sparing adrenalectomy for patients with bilateral pheochromocytoma. Surgery 1996;120:1064-1070.
72. Walther MM, Keiser HR, Choyke PL et al. Management of hereditary pheochromocytoma in von Hippel-Lindau kindreds with partial adrenalectomy. J Urol 1999;161:395-398.
73. Janetschek G, Lhotta K, Gasser R et al. Adrenal-sparing laparoscopic surgery for aldosterone-producing adenoma. J Endourol 1997;11:145-148.
74. Al-Sobhi S, Peschel R, Bartsch G et al. Partial laparoscopic adrenalectomy for aldosterone-producing adenoma: short- and long-term results. J Endourol 2000;14:497-499.
75. Jeschke K, Janetschek G, Peschel R et al. Laparoscopic partial adrenalectomy in patients with aldosterone-producing adenomas: indications, technique, and results. Urology 2003;61:69-72.
76. Lairmore TC, Ball DW, Baylin SB et al. Management of pheochromocytomas in patients with multiple endocrine neoplasia type 2 syndromes. Ann Surg 1993;217:595-601.
77. Walther MM, Herring J, Choyke PL et al. Laparoscopic partial adrenalectomy in patients with hereditary forms of pheochromocytoma. J Urol 2000;164:14-17.